# Insulin Tolerance Test Study in Patients With Type 1 Diabetes

> **NCT04026750** · PHASE1 · TERMINATED · sponsor: **High Point Clinical Trials Center** · enrollment: 5 (actual)

## Conditions studied

- Type 1 Diabetes
- Hypoglycemia

## Interventions

- **DRUG:** Pitolisant

## Key facts

- **NCT ID:** NCT04026750
- **Lead sponsor:** High Point Clinical Trials Center
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-15
- **Primary completion:** 2020-02-16
- **Final completion:** 2020-02-16
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Based on scientific data collected during the trial and high screen fail rate.
- **Last updated:** 2021-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04026750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04026750, "Insulin Tolerance Test Study in Patients With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04026750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*